Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter. Life and the stock market are both about expectations, and rising above what is expected is often rewarded, while falling short can come with negative consequences. Investors might want to try to capture stronger returns by finding positive earnings surprises. 2 Stocks to Add to Your Watchlist The Zacks Earnings ESP, or Expected Surprise Prediction, aims to find earnings surprises by focusing on the most recent analyst revisions. The basic premise is that if an analyst reevaluates their earnings estimate ahead of an earnings release, it means they likely have new information that could possibly be more accurate. The core of the ESP model is comparing the Most Accurate Estimate to the Zacks Consensus Estimate, where the resulting percentage difference between the two equals the Expected Surprise Prediction. The last thing we will do today, now that we have a grasp on the ESP and how powerful of a tool it can be, is to look at a qualifying stock. Eli Lilly (LLY) holds a Zacks Rank #3 at the moment and its Most Accurate Estimate comes in at $2.82 a share 28 days away from its upcoming earnings release on August 8, 2024. By taking the percentage difference between the $2.82 Most Accurate Estimate and the $2.65 Zacks Consensus Estimate, Eli Lilly has an Earnings ESP of 6.49%. LLY is part of a big group of Medical stocks that boast a positive ESP, and investors may want to take a look at HCA Healthcare (HCA) as well. HCA Healthcare is a Zacks Rank #2 (Buy) stock, and is getting ready to report earnings on July 23, 2024. HCA's Most Accurate Estimate sits at $5.32 a share 12 days from its next earnings release. The Zacks Consensus Estimate for HCA Healthcare is $4.97, and when you take the percentage difference between that number and its Most Accurate Estimate, you get the Earnings ESP figure of 7.1%. LLY and HCA's positive ESP metrics may signal that a positive earnings surprise for both stocks is on the horizon. Find Stocks to Buy or Sell Before They're Reported Use the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Eli Lilly and Company (LLY):Free Stock Analysis Report HCA Healthcare, Inc. (HCA):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...